New pyridobenzodiazepine derivatives: modifications of the basic side chain differentially modulate binding to dopamine (D(4.2), D(2L)) and serotonin (5-HT(2A)) receptors.
第一作者:
Jean-François,Liégeois
第一单位:
Natural and Synthetic Drugs Research Center, Laboratory of Medicinal Chemistry, University of Liège, avenue de l'Hôpital 1 (B36), Belgium. JF.Liegeois@ulg.ac.be
作者:
医学主题词
胺类(Amines);动物(Animals);抗抑郁药(Antidepressive Agents);苯二氮|艹卓|类(Benzodiazepines);僵住症(Catalepsy);细胞系(Cell Line);多巴胺药(Dopamine Agents);女(雌)性(Female);人类(Humans);小鼠(Mice);分子构象(Molecular Conformation);哌嗪类(Piperazines);哌啶类(Piperidines);放射配体测定(Radioligand Assay);大鼠(Rats);大鼠, Wistar(Rats, Wistar);受体, 血清素, 5-HT2A(Receptor, Serotonin, 5-HT2A);受体, 肾上腺素能α1(Receptors, Adrenergic, alpha-1);受体, 多巴胺D2(Receptors, Dopamine D2);受体, 多巴胺D4(Receptors, Dopamine D4);受体, 血清素(Receptors, Serotonin);血清素类药(Serotonin Agents);构效关系(Structure-Activity Relationship)
DOI
10.1021/jm0104825
PMID
12408724
发布时间
2019-07-10
- 浏览12
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



